Home

Doximity, Inc. Class A Common Stock (DOCS)

67.57
+0.24 (0.36%)
NYSE · Last Trade: Oct 18th, 6:08 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close67.33
Open66.97
Bid67.08
Ask70.84
Day's Range66.57 - 67.94
52 Week Range40.87 - 85.21
Volume881,422
Market Cap12.51B
PE Ratio (TTM)57.75
EPS (TTM)1.2
Dividend & YieldN/A (N/A)
1 Month Average Volume1,405,745

Chart

About Doximity, Inc. Class A Common Stock (DOCS)

Doximity Inc is a digital platform designed specifically for medical professionals, primarily physicians, to enhance communication and collaboration within the healthcare community. The platform provides a range of tools and resources, including secure messaging, telehealth services, and access to a network of healthcare professionals, allowing doctors to connect with each other and stay updated on medical news and developments. Additionally, Doximity offers features such as electronic faxing, a comprehensive directory of healthcare providers, and opportunities for continuing medical education, all aimed at improving clinical workflows and ultimately enhancing patient care. Read More

News & Press Releases

Doximity to Release Fiscal 2026 Second Quarter Results on November 6, 2025
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ended September 30, 2025 after market close on November 6, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results.
By Doximity · Via Business Wire · October 16, 2025
2 Unpopular Stocks That Deserve Some Love and 1 Facing Challenges
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Via StockStory · October 14, 2025
ZoomInfo, Upstart, F5, Procore Technologies, and Doximity Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after President Donald Trump eased concerns over escalating trade tensions with China, calming markets rattled by his earlier tariff threats. 
Via StockStory · October 13, 2025
What's Driving the Market Sentiment Around Doximity?benzinga.com
Via Benzinga · September 12, 2025
Doximity (DOCS): 3 Reasons We Love This Stock
Doximity trades at $64.99 per share and has stayed right on track with the overall market, gaining 23.6% over the last six months. At the same time, the S&P 500 has returned 21.1%.
Via StockStory · October 13, 2025
Why Doximity (DOCS) Shares Are Trading Lower Today
Shares of medical professional network Doximity (NYSE:DOCS) fell 6.7% in the morning session after JP Morgan downgraded the stock to 'Underweight' from 'Neutral', citing concerns about its high valuation and uncertainty in advertising trends. 
Via StockStory · October 10, 2025
This Keysight Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Fridaybenzinga.com
Via Benzinga · October 10, 2025
Doximity Inc-Class A (NYSE:DOCS): A Strong Growth Stock with a Bullish Technical Setupchartmill.com
Doximity (DOCS) shows strong growth, high profitability, and a positive technical setup, making it a notable stock for growth-focused investors.
Via Chartmill · October 10, 2025
Fastly, Elastic, LiveRamp, Doximity, and SentinelOne Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after confidence in the artificial intelligence market was renewed, pushing both the S&P 500 and Nasdaq to new all-time intraday highs. 
Via StockStory · October 8, 2025
Doximity, Bentley Systems, Zeta Global, Guidewire Software, and SoundHound AI Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after markets pulled back as a report raised concerns about artificial intelligence demand and profitability. 
Via StockStory · October 7, 2025
Doximity Inc (DOCS) Stock: A High-Growth Pick with Strong Technical Setupchartmill.com
Discover Doximity (DOCS), a stock with strong earnings growth and a bullish technical chart pattern, offering a potential entry point for momentum investors.
Via Chartmill · October 7, 2025
1 Cash-Heavy Stock to Own for Decades and 2 Facing Challenges
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
Via StockStory · October 6, 2025
Doximity Inc-Class A (NYSE:DOCS): A Caviar Cruise Strategy Candidatechartmill.com
Doximity (DOCS) excels as a Caviar Cruise investment with strong revenue growth, 172% ROIC, and robust cash flow, showcasing a high-quality digital health platform.
Via Chartmill · October 2, 2025
Assessing Doximity: Insights From 12 Financial Analystsbenzinga.com
Via Benzinga · October 1, 2025
Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation
Johnson Fistel, PLLP is investigating potential legal claims on behalf of Doximity, Inc. (NYSE: DOCS) shareholders, concerning alleged misconduct by certain officers and directors that may have harmed the company and its investors.
By Johnson Fistel, PLLP · Via Business Wire · October 1, 2025
Why Doximity (DOCS) Stock Is Down Today
Shares of medical professional network Doximity (NYSE:DOCS) fell 3.2% in the afternoon session after Goldman Sachs downgraded the stock to Sell from a Neutral rating. The investment bank cited concerns over the company's high valuation and slowing growth, which it believes create an unfavorable risk/reward scenario for investors. Goldman Sachs set a price target of $64 for the stock.
Via StockStory · October 1, 2025
Congressional Trading Report: Rep. Jonathan Jackson Bought Over $16K In Doximity Stockbenzinga.com
Via Benzinga · September 24, 2025
2 Software Stocks Worth Your Attention and 1 We Ignore
Software is rapidly reducing operating expenses for businesses. This secular theme makes SaaS companies attractive investment candidates but also comes with higher valuations that make re-ratings harder. Unfortunately, the rich prices have held them back over the past six months as the industry’s gain of 10.1% has fallen short of the S&P 500’s 16.2% rise.
Via StockStory · September 23, 2025
2 High-Flying Stocks Worth Your Attention and 1 We Question
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.
Via StockStory · September 16, 2025
1 Mid-Cap Stock on Our Watchlist and 2 We Question
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.
Via StockStory · September 12, 2025
Expert Outlook: Doximity Through The Eyes Of 11 Analystsbenzinga.com
Via Benzinga · September 11, 2025
Q2 Rundown: Doximity (NYSE:DOCS) Vs Other Vertical Software Stocks
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the vertical software stocks, including Doximity (NYSE:DOCS) and its peers.
Via StockStory · September 7, 2025
Doximity Inc-Class A (NYSE:DOCS) Emerges as a Top Growth and Momentum Stockchartmill.com
Doximity (DOCS) is a top growth stock with strong fundamentals, including 19% revenue growth and a debt-free balance sheet, now showing a bullish technical breakout pattern.
Via Chartmill · September 5, 2025
2 Profitable Stocks for Long-Term Investors and 1 That Underwhelm
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Via StockStory · September 5, 2025
Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation
Johnson Fistel, PLLP is investigating potential legal claims on behalf of Doximity, Inc. (NYSE: DOCS) shareholders, concerning alleged misconduct by certain officers and directors that may have harmed the company and its investors.
By Johnson Fistel, PLLP · Via Business Wire · August 26, 2025